Jing W[au] - Search Results

Year	Number of Results
1984	2
1986	1
1988	1
1989	2
1990	1
1992	1
1993	1
1994	2
1995	2
1997	3
1998	3
1999	1
2000	4
2001	1
2002	5
2003	8
2004	9
2005	11
2006	10
2007	18
2008	22
2009	20
2010	19
2011	31
2012	35
2013	60
2014	61
2015	61
2016	67
2017	78
2018	99
2019	101
2020	117
2021	148
2022	68

1

Motivating role of type H vessels in bone regeneration.

Zhang J, Pan J, Jing W. Zhang J, et al. Among authors: jing w. Cell Prolif. 2020 Sep;53(9):e12874. doi: 10.1111/cpr.12874. Epub 2020 Jul 19. Cell Prolif. 2020. PMID: 33448495 Free PMC article. Review.

2

Countdown to 2030: eliminating hepatitis B disease, China.

Liu J, Liang W, Jing W, Liu M. Liu J, et al. Among authors: jing w. Bull World Health Organ. 2019 Mar 1;97(3):230-238. doi: 10.2471/BLT.18.219469. Epub 2019 Jan 28. Bull World Health Organ. 2019. PMID: 30992636 Free PMC article.

3

Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.

Ma D, Yang M, Wang Q, Sun C, Shi H, Jing W, Bi Y, Shen X, Ma X, Qin Z, Lin Y, Zhu L, Zhao Y, Cheng Y, Han L. Ma D, et al. Among authors: jing w. Sci Adv. 2021 Mar 24;7(13):eabc1834. doi: 10.1126/sciadv.abc1834. Print 2021 Mar. Sci Adv. 2021. PMID: 33762328 Free PMC article.

4

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection.

Zhang J, Chen C, Li A, Jing W, Sun P, Huang X, Liu Y, Zhang S, Du W, Zhang R, Liu Y, Gong A, Wu J, Jiang X. Zhang J, et al. Among authors: jing w. Nat Nanotechnol. 2021 May;16(5):538-548. doi: 10.1038/s41565-020-00843-7. Epub 2021 Feb 1. Nat Nanotechnol. 2021. PMID: 33526838

5

The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.

Zhai X, Zhang J, Tian Y, Li J, Jing W, Guo H, Zhu H. Zhai X, et al. Among authors: jing w. Cancer Biol Med. 2020 Aug 15;17(3):599-611. doi: 10.20892/j.issn.2095-3941.2020.0102. Cancer Biol Med. 2020. PMID: 32944393 Free PMC article. Review.

6

Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review.

Guo Y, Song J, Wang Y, Huang L, Sun L, Zhao J, Zhang S, Jing W, Ma J, Han C. Guo Y, et al. Among authors: jing w. Front Oncol. 2020 Dec 10;10:610923. doi: 10.3389/fonc.2020.610923. eCollection 2020. Front Oncol. 2020. PMID: 33363040 Free PMC article. Review.

7

Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.

Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H. Jing W, et al. Pharmacol Res. 2021 Feb;164:105358. doi: 10.1016/j.phrs.2020.105358. Epub 2020 Dec 4. Pharmacol Res. 2021. PMID: 33285228

8

Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.

Dong S, Zhu M, Wang K, Zhao X, Hu L, Jing W, Lu H, Wang S. Dong S, et al. Among authors: jing w. Pharmacol Res. 2021 Sep;171:105767. doi: 10.1016/j.phrs.2021.105767. Epub 2021 Jul 14. Pharmacol Res. 2021. PMID: 34273490

9

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models.

Jing W, McAllister D, Vonderhaar EP, Palen K, Riese MJ, Gershan J, Johnson BD, Dwinell MB. Jing W, et al. J Immunother Cancer. 2019 Apr 29;7(1):115. doi: 10.1186/s40425-019-0573-5. J Immunother Cancer. 2019. PMID: 31036082 Free PMC article.

10

FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-Mediated Bladder Cancer Immune Surveillance.

Jing W, Wang G, Cui Z, Xiong G, Jiang X, Li Y, Li W, Han B, Chen S, Shi B. Jing W, et al. Cancer Res. 2022 Jan 1;82(1):114-129. doi: 10.1158/0008-5472.CAN-21-2362. Epub 2021 Nov 9. Cancer Res. 2022. PMID: 34753771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results